Company intelligence / Profile preview
Eton Pharmaceuticals
- Ownership
- Public · ETON
- Employees
- ~30
- Development stage
- Commercial
Overview
Eton Pharmaceuticals has seven commercial rare disease products and four additional product candidates in late-stage development. The company leverages the FDA’s 505(b)(2) regulatory pathway to expedite approvals. Its focus on rare diseases—especially pediatric populations—has resulted in multiple FDA approvals within a short period. Recent clinical results have been positive; pivotal studies support ongoing NDA submissions and anticipated launches.
- Therapeutic areas
- EndocrinologyNeurologyMetabolic Disorders
- Modalities
- Small moleculeBiologicInjectableOral liquid formulations
- Industry
- Biotech
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →Partnerships
Financials
- Market cap
- $1.6B
- Total revenue
- $37.6M
- Enterprise value
- $1.6B
Beyond the preview
Go deeper on Eton Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eton Pharmaceuticals.